[177Lu]Lu-SN201

· Spago Nanomedical AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-SN201, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer [Phase 1, Phase 2]